本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Revolution Medicines, Inc.

38.02
-0.4800-1.25%
盤後38.020.00000.00%17:23 EDT
成交量:140.23萬
成交額:5,338.02萬
市值:70.82億
市盈率:-9.46
高:38.47
開:38.26
低:37.85
收:38.50
資料載入中...
2024/10/25

重要事件披露

Form 8-K - Current report
2024/10/23

重要事件披露

Form 8-K - Current report
2024/10/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/07

重要事件披露

Form 8-K - Current report
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]